On April 11, 2024, Ocugen Inc. was sued for violations of the federal securities laws in the United States District Court for the Eastern District of Pennsylvania on behalf of investors who purchased or otherwise acquired publicly traded Ocugen securities between May 8, 2020 and April 1, 2024, inclusive (the “Class Period”).
We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.